View Profile

Malu Gamez Tansey

Professor/ Neurology · Indiana University School of Medicine

https://researchid.co/mgtansey
@medicine.iu.edu
23882Google Scholar Citations
76Google Scholar h-index
153Google Scholar i10-index

Biography

Malú Gámez Tansey, Ph.D. is the James A. Caplin MD, Chair in Alzheimer’s Disease and Professor of Neurology, Director of Neuroimmunology Research Group, and Executive Associate Director of Education at the Stark Neuroscience Research Institute at Indiana University School of Medicine. She investigates the role of central-peripheral immune crosstalk in brain health and neurodegenerative diseases and the gut-brain axis, with the long-term goal of developing better therapies for patients. Dr. Tansey obtained her B.S/M.S in Biological Sciences from Stanford University and her Ph.D. in Cell Regulation from UT Southwestern followed by post-doctoral work in neuroscience at Washington University. As head of Chemical Genetics at Xencor, she co-invented novel soluble TNF inhibitors that have now advanced to clinical trials in Alzheimer’s disease.

Education

B.S and M.S Biological Sciences from Stanford University PhD in Cell Regulation from UT Southwestern Graduate School in Dallas, TX

Recent Google Scholar Publications

  1. Regulator of G protein signaling 10: a critical regulator of chronic systemic inflammation in parkinson’s disease
    Journal of Neuroinflammation , 2026, 2026
  2. XPro1595 in early Alzheimer’s disease with inflammation: results from the phase 2 MINDFuL trial
    npj Dementia 2 (1), 37 , 2026, 2026
  3. Intestinal inflammation promotes neuroinflammation and PD-associated nigrostriatal pathology independently of LRRK2 G2019S kinase activity
    Frontiers in Cellular Neuroscience 20, 1794784 , 2026, 2026
  4. Parkinson's‐Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa
    Movement Disorders 41 (3), 651-666 , 2026, 2026 | Citations: 2.0
  5. Profiling peripheral immune cells in Parkinson’s disease: A Scoping Review
    bioRxiv, 2026.02. 17.706426 , 2026, 2026

Grants / Consultancy

None Multiple biotechs and pharmaceutical companies. Multiple SABs and Advisory Groups.

Links